Latest News in the pharma Industry

Biopharma News

Grant winners to investigate continuous manufacturing for gene therapies

Grant winners to investigate continuous manufacturing for gene therapies

26 Nov 2018

Cobra Biologics, Pall, and the Cell and Gene Therapy Catapult share £1.5 million grant from the UK's innovation agency.

Read more 
ADC Bio secures additional equity round investment

ADC Bio secures additional equity round investment

19 Nov 2018

Extra funding for strategic move into downstream formulation and fill finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm.

Read more 
SSB and Lonza modify relationship for supply of cell culture media

SSB and Lonza modify relationship for supply of cell culture media

18 Nov 2018

Sartorius Stedim Biotech will continue to offer Lonza media and buffer products but under a non-exclusive agreement.

Read more 
bioLIVE to merge with BioProduction Congress for 2019 event

bioLIVE to merge with BioProduction Congress for 2019 event

7 Nov 2018

BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the bio industry.

Read more 
Sandoz pulls the plug on US biosimilar rituximab

Sandoz pulls the plug on US biosimilar rituximab

4 Nov 2018

Company will focus on robust biosimilar portfolio for unmet access and sustainability needs.

Read more 
Three-way collaboration to advance gene therapy

Three-way collaboration to advance gene therapy

4 Oct 2018

Partnership aims to increase the robustness and reduce costs for the manufacturing of AAV vectors.

Read more 
Bioconjugation expertise and increased productivity in bio over next 5 years

Bioconjugation expertise and increased productivity in bio over next 5 years

28 Sep 2018

Smaller bioreactors and high-density perfusion techniques needed as manufacturing makes significant efficiency improvements.

Read more 
Alvotech receives manufacturing licence for its biopharmaceutical facility

Alvotech receives manufacturing licence for its biopharmaceutical facility

27 Sep 2018

Facility to focus on developing and manufacturing the company's biosimilar portfolio.

Read more 
Complete product lifecycle management in one location

Complete product lifecycle management in one location

23 Sep 2018

Lonza expansion includes drug substance development, and drug substance and drug product manufacturing.

Read more 
BIA Separations expands with new upstream processing facility

BIA Separations expands with new upstream processing facility

20 Sep 2018

Provides single source of expertise for scaled production of complex biologics for gene therapy and vaccines.

Read more 
Partnership to deliver integrated, off-the-shelf biosimilar manufacturing solutions

Partnership to deliver integrated, off-the-shelf biosimilar manufacturing solutions

17 Sep 2018

Pall and Aetos to advance the market impact of biosimilars and deliver lower-priced, high-quality options to end users.

Read more 
Aptar Pharma to showcase an industry first

Aptar Pharma to showcase an industry first

12 Sep 2018

PureHale is a new portable drug delivery device designed for upper respiratory care.

Read more